The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis.
Cells have evolved a number of control pathways that delay or prevent them from entering mitosis under conditions that can compromise genome integrity. One recently appreciated and versatile control pathway involves the p38 stress activated protein kinase. During late G2 p38 is rapidly activated by diverse stresses (topoisomerase II (topo II)) and histone deacetylase inhibitors, osmotic shock, microtubule disassembly, UV light, etc) via a number of different pathways. Once activated p38 appears to delay entry into mitosis by inhibiting cdc25B phosphatase that, in turn, down-regulates cyclin A/CDK2 activity. Depending on the agent and degree of stress, this delay may be transient, or it may last until transcription mediated checkpoint pathways can take over.
Mikhailov
Alexei
A
Lab of Cell Regulation, Wadsworth Center, New York State Department of Health, Albany, New York 12201-0509, USA. alexeim@Wadsorth.org
Shinohara
Mio
M
Rieder
Conly L
CL
D000818:Animals; D002453:Cell Cycle / Q000235:genetics / Q000502:physiology*; D002455:Cell Division / Q000235:genetics / Q000502:physiology; D004249:DNA Damage / Q000235:genetics / Q000502:physiology; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004789:Enzyme Activation; D016195:G2 Phase / Q000235:genetics / Q000502:physiology; D006801:Humans; D008938:Mitosis / Q000235:genetics / Q000502:physiology*; D014158:Transcription, Genetic; D048051:p38 Mitogen-Activated Protein Kinases / Q000235:genetics / Q000378:metabolism*
D048051:p38 Mitogen-Activated Protein Kinases; D004250:DNA Topoisomerases, Type II